www.uniqure.com Open in urlscan Pro
20.49.104.15  Public Scan

Form analysis
0 forms found in the DOM

Text Content

This website uses cookies to track its audience and improve its content. By
continuing to browse this website, you agree to the use of such cookies. For
more information on cookies, please refer to our Privacy Policy.
Continue
uniQure
 * Pioneers & Leaders
   * Our Story
   * Our Leadership
   * Our Partners
   
 * Patients & Families
   * Huntington's Disease
   * Hemophilia B
   * Patient Stories
   * Community Resources
   
 * Science & Innovation
   * Our Platform
   * Enabling Technologies
   * Our Manufacturing
   * Publications
   
 * Programs & Pipeline
   * Huntington's Disease
   * Hemophilia B
   * Clinical Trials
   * Research Programs
   * Pipeline
   
 * Investors & Media
   * Shareholder & Stock Info
   * Corporate Governance
   * Press Releases
   * Events & Presentations
   * Analyst Coverage
   * SEC Filings
   * Investor FAQ
   
 * Culture & Careers
   * Working at uniQure
   * Social Responsibility
   * Our People
   * Job Opportunities
   
 * Contact Us

Menu


REIMAGINING THE FUTURE OF HEALTHCARE

ROB / Clinical trial patient for etranacogene dezaparvovec



Genomic medicine has the potential to transform healthcare as we know it today.
And for more than two decades, we at uniQure have been working tirelessly to
harness this power to deliver breakthrough treatments that change patients’
lives. We won’t stop until we do.



REIMAGINING PATIENT CARE

An everyday, all-encompassing focus on patients and their families.

Patients & Families



REIMAGINING OUR PLATFORM

Creating the future with exciting new technologies and proven manufacturing.

Science & Innovation



REIMAGINING OUR PIPELINE

Translating leading science into a growing pipeline of promising programs.

Programs & Pipeline



REIMAGINING HOW WE WORK TOGETHER

Nurturing greatness through the power of people working together.

Culture & Careers



WE ARE UNIQURE

More than 20 years of innovation, industry firsts and partnerships in
gene therapy.

About uniQure



SPOTLIGHT: AN INTERVIEW WITH MATT KAPUSTA




PRESS RELEASES

Subscribe to receive breaking news alerts about uniQure.

Subscribe
 * Oct 3, 2022
   
   UNIQURE TO PARTICIPATE IN UPCOMING INDUSTRY CONFERENCES IN OCTOBER

 * Sep 6, 2022
   
   UNIQURE TO PARTICIPATE IN UPCOMING INDUSTRY CONFERENCES IN SEPTEMBER

 * Aug 8, 2022
   
   UNIQURE ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS AND HIGHLIGHTS RECENT
   COMPANY PROGRESS

See All


FOLLOW US @UNIQURE_NV

 * uniQure uniQure_NV
   
   Congrats to uniQure's Tom Malone and to all the members of Team Run for HD
   for completing today's #ChicagoMarathon in support of the @HDSA!
   https://t.co/qd32RQYOGh
   
   
   9 Oct 2022
 * uniQure uniQure_NV
   
   This past weekend, we had the opportunity to be at the @HDSAlosangeles Hope &
   Cope event. This was the first time, in 2 years that the #HDcommunity in Los
   Angeles had an opportunity to gather at an educational event.
   https://t.co/MM8eKUr0uN
   
   
   5 Oct 2022
 * uniQure uniQure_NV
   
   This Sunday we'll be cheering on uniQure's Tom Malone as he runs the
   #ChicagoMarathon in support of the @HDSA Upper Great Lakes region! uniQure
   supports the HDSA in its mission to improve the lives of everyone affected by
   #huntingtonsdisease. https://t.co/Q2sTaYBSQF https://t.co/v0ezuk50Mp
   
   
   4 Oct 2022

uniQure
uniQure N.V.
Paasheuvelweg 25a, 1105 BP
Amsterdam
Chamber of Commerce
34275365
 * Pioneers & Leaders
 * Patients & Families
 * Science & Innovation
 * Programs & Pipeline
 * Investors & Media
 * Culture & Careers
 * Contact

Follow us on social

 * 
 * 
 * 

©2022 uniQure NV. All rights reserved.

 * Sitemap
 * Disclaimer
 * Privacy Statement

uniQure Logo Twitter Icon LinkedIn Icon YouTube Icon Twitter Icon Arrow
Slideshow Next Button

×